Cheng Chun-Han, Hao Wen-Rui, Cheng Tzu-Hurng
Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan.
Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei 23561, Taiwan.
World J Diabetes. 2024 Nov 15;15(11):2264-2271. doi: 10.4239/wjd.v15.i11.2264.
Recent advancements in stem cell-derived exosome therapy for diabetic brain hemorrhage are discussed in this editorial, which highlights this therapy's potential for revolutionizing diabetic brain hemorrhage treatment. The paper offers compelling evidence that exosomes can effectively reduce neuroinflammation and promote recovery from diabetic brain hemorrhage. Although these findings are promising, further research is warranted to fully understand the underlying mechanisms and to validate the therapeutic potential of exosomes in clinical settings. The findings of this study indicate that continued exploration should be conducted into exosome-based therapies as a novel approach to managing diabetic brain hemorrhage.
本社论讨论了干细胞衍生外泌体疗法在糖尿病性脑出血治疗方面的最新进展,强调了该疗法在革新糖尿病性脑出血治疗方面的潜力。该论文提供了令人信服的证据,表明外泌体可有效减轻神经炎症并促进糖尿病性脑出血的恢复。尽管这些发现很有前景,但仍需进一步研究以充分了解其潜在机制,并在临床环境中验证外泌体的治疗潜力。这项研究的结果表明,应继续探索基于外泌体的疗法,将其作为治疗糖尿病性脑出血的一种新方法。